Skip to main content

Table 3 Correlation of the percentage of ALK-positive and the response to crizotinib in ALK-positive NSCLC patients

From: Pathological cytomorphologic features and the percentage of ALK FISH-positive cells predict pulmonary adenocarcinoma prognosis: a prospective cohort study

Response

NO. of patients (N = 60) (%)

P value

ALK-positive

≥ 50% (N = 37)

ALK-positive

< 50% (N = 23)

ORR,%

83.8% (31/37)

60.9% (14/23)

0.046

DCR,%

89.2% (33/37)

82.3% (19/23)

0.735